Index S&P 500
P/E 28.03
EPS (ttm) 12.18
Insider Own 1.82%
Shs Outstand 292.50M
Perf Week -3.66%
Market Cap 97.01B
Forward P/E 10.65
EPS next Y 32.05
Insider Trans -3.06%
Shs Float 278.91M
Perf Month -5.24%
Income 3.62B
PEG 2.34
EPS next Q 6.64
Inst Own 91.28%
Short Float 1.41%
Perf Quarter 5.45%
Sales 204.15B
P/S 0.48
EPS this Y 13.49%
Inst Trans -1.59%
Short Ratio 2.63
Perf Half Y 10.37%
Book/sh 144.90
P/B 2.36
EPS next Y 12.57%
ROA 2.49%
Short Interest 3.95M
Perf Year 38.82%
Cash/sh -
P/C -
EPS next 5Y 11.97%
ROE 8.45%
52W Range 240.50 - 365.71
Perf YTD 14.04%
Dividend Est. 6.70 (1.96%)
P/FCF 9.55
EPS past 5Y 10.54%
ROI 5.01%
52W High -6.62%
Beta 0.56
Dividend TTM 5.09 (1.49%)
Quick Ratio -
Sales past 5Y 48.25%
Gross Margin -
52W Low 42.00%
ATR (14) 6.43
Dividend Ex-Date Jun 04, 2024
Current Ratio 0.83
EPS Y/Y TTM -44.66%
Oper. Margin 3.65%
RSI (14) 33.91
Volatility 2.64% 1.73%
Employees 72500
Debt/Eq 0.80
Sales Y/Y TTM 11.68%
Profit Margin 1.77%
Recom 1.54
Target Price 393.48
Option/Short Yes / Yes
LT Debt/Eq 0.75
EPS Q/Q -122.82%
Payout 28.29%
Rel Volume 1.61
Prev Close 344.50
Sales Surprise 1.15%
EPS Surprise 4.02%
Sales Q/Q 19.28%
Earnings May 02 BMO
Avg Volume 1.50M
Price 341.50
SMA20 -3.31%
SMA50 -2.54%
SMA200 10.33%
Trades
Volume 2,406,253
Change -0.87%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-06-24 Initiated
Barclays
Overweight
$393
Feb-05-24 Upgrade
RBC Capital Mkts
Sector Perform → Outperform
$327 → $354
Feb-05-24 Upgrade
Cantor Fitzgerald
Neutral → Overweight
$334 → $372
Feb-01-24 Upgrade
Deutsche Bank
Hold → Buy
$355 → $370
Jan-04-24 Upgrade
Bernstein
Mkt Perform → Outperform
$330 → $372
Dec-11-23 Upgrade
Jefferies
Hold → Buy
$335 → $341
Aug-18-23 Downgrade
Edward Jones
Buy → Hold
Jun-06-23 Upgrade
BofA Securities
Neutral → Buy
$320
Apr-21-23 Initiated
Cantor Fitzgerald
Neutral
$285
Apr-05-23 Upgrade
Raymond James
Outperform → Strong Buy
$350
Jan-03-23 Downgrade
Wells Fargo
Overweight → Equal Weight
$370 → $355
Nov-23-22 Resumed
Morgan Stanley
Overweight
$318 → $347
Nov-21-22 Downgrade
Raymond James
Strong Buy → Outperform
$370
Jul-14-22 Downgrade
Jefferies
Buy → Hold
$330 → $271
Jun-22-22 Upgrade
Morgan Stanley
Equal-Weight → Overweight
$283 → $296
Jun-17-22 Initiated
Loop Capital
Hold
$270
May-27-22 Resumed
Bernstein
Mkt Perform
$258 → $301
May-26-22 Upgrade
BofA Securities
Underperform → Neutral
$265 → $300
May-16-22 Upgrade
JP Morgan
Neutral → Overweight
$248 → $304
May-09-22 Upgrade
Cowen
Market Perform → Outperform
$242 → $329
Show Previous Ratings
May-03-24 12:37PM
12:22PM
10:53AM
10:53AM
10:53AM
10:52AM
Loading…
10:52AM
08:40AM
08:05AM
03:19AM
01:03AM
May-02-24 11:49PM
(Thomson Reuters StreetEvents)
04:01PM
03:30PM
02:54PM
01:30PM
01:28PM
Loading…
01:28PM
(The Wall Street Journal)
12:38PM
11:54AM
10:55AM
07:32AM
07:10AM
06:48AM
06:48AM
06:08AM
(Associated Press Finance)
06:03AM
06:00AM
06:00AM
May-01-24 04:57PM
09:46AM
Apr-30-24 11:55AM
10:30AM
Loading…
10:30AM
(Investor's Business Daily)
06:15AM
Apr-29-24 05:22PM
09:40AM
09:16AM
Apr-26-24 07:00AM
Apr-25-24 04:48PM
04:30PM
11:50AM
10:10AM
10:02AM
Apr-24-24 04:30PM
Apr-23-24 06:00PM
09:00AM
Apr-22-24 04:21PM
01:37PM
09:50AM
Apr-18-24 06:15PM
07:00AM
Apr-17-24 12:10PM
Apr-16-24 01:47PM
(The Wall Street Journal)
10:01AM
04:13AM
Apr-15-24 04:46AM
Apr-12-24 06:15PM
09:40AM
Apr-11-24 09:00AM
Apr-09-24 01:16PM
Apr-04-24 06:15PM
Apr-03-24 04:09PM
02:46PM
Apr-02-24 04:01PM
(Investor's Business Daily)
11:33AM
07:04AM
Apr-01-24 03:43PM
Mar-31-24 11:03PM
Mar-30-24 01:00PM
Mar-28-24 04:05PM
09:33AM
Mar-27-24 06:15PM
09:40AM
Mar-25-24 09:30AM
Mar-24-24 11:00AM
Mar-21-24 08:02PM
Mar-18-24 06:15PM
Mar-14-24 09:15AM
Mar-12-24 06:15PM
10:24AM
Mar-08-24 11:16AM
10:32AM
10:15AM
09:13AM
05:31AM
01:57AM
(Thomson Reuters StreetEvents)
Mar-07-24 06:22PM
03:03PM
01:47PM
01:12PM
09:30AM
07:13AM
07:10AM
06:54AM
06:45AM
Mar-06-24 11:56AM
Mar-05-24 10:54AM
Mar-04-24 05:02AM
Mar-01-24 12:07AM
Feb-29-24 09:50AM
Feb-28-24 09:10AM
Feb-27-24 09:40AM
The Cigna Group is a global health company, which engages in the provision of global health services. It operates through the following segments: Evernorth Health Services, Cigna Healthcare, Other Operations, and Corporate. The Evernorth Health Services segment partners with health plans, employers, governmental organizations, and health care providers to solve challenges in the areas of pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty distribution, and care delivery and management solutions. The Cigna Healthcare segment includes the U.S. Healthcare and International Health operating segments, which provide comprehensive medical and coordinated solutions to clients and customers. The Other Operations segment consists of the remainder of business operations, which includes certain ongoing businesses and exited businesses. The Corporate segment refers to net interest expense, certain litigation matters, expense associated with frozen pension plans, charitable contributions, operating severance, certain overhead and enterprise-wide project costs, and eliminations for products and services sold between segments. The company was founded in 1792 and is headquartered in Bloomfield, CT.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Cordani David Chairman & CEO Mar 26 '24 Option Exercise 139.22 7,761 1,080,486 355,815 Mar 28 05:14 PM Cordani David Chairman & CEO Mar 25 '24 Option Exercise 139.22 31,209 4,344,917 379,263 Mar 25 06:19 PM Cordani David Chairman & CEO Mar 25 '24 Sale 355.17 31,209 11,084,357 348,054 Mar 25 06:19 PM Cordani David Chairman & CEO Mar 22 '24 Option Exercise 139.22 6,338 882,376 354,392 Mar 25 06:19 PM Cordani David Chairman & CEO Mar 22 '24 Sale 355.11 6,338 2,250,682 348,054 Mar 25 06:19 PM Cordani David Chairman & CEO Mar 21 '24 Option Exercise 139.22 2,293 319,231 350,347 Mar 25 06:19 PM Cordani David Chairman & CEO Mar 21 '24 Sale 355.02 2,293 814,052 348,054 Mar 25 06:19 PM Cordani David Chairman & CEO Mar 14 '24 Option Exercise 139.22 7,616 1,060,300 348,054 Mar 14 06:09 PM Cordani David Chairman & CEO Mar 13 '24 Option Exercise 139.22 13,761 1,915,806 354,199 Mar 14 06:09 PM Cordani David Chairman & CEO Mar 13 '24 Sale 347.33 13,761 4,779,542 340,438 Mar 14 06:09 PM Cordani David Chairman & CEO Mar 12 '24 Option Exercise 139.22 2,238 311,574 342,676 Mar 14 06:09 PM Cordani David Chairman & CEO Mar 12 '24 Sale 345.00 2,238 772,121 340,438 Mar 14 06:09 PM Cordani David Chairman & CEO Mar 08 '24 Option Exercise 139.22 2,801 389,955 343,239 Mar 11 05:38 PM Cordani David Chairman & CEO Mar 08 '24 Sale 345.19 2,801 966,883 340,438 Mar 11 05:38 PM Cordani David Chairman & CEO Mar 07 '24 Option Exercise 139.22 2,412 335,799 342,850 Mar 11 05:38 PM Cordani David Chairman & CEO Mar 07 '24 Sale 345.73 2,412 833,892 340,438 Mar 11 05:38 PM Cordani David Chairman & CEO Mar 04 '24 Sale 332.62 19,288 6,415,575 340,438 Mar 05 05:43 PM Jones Nicole S See Remarks Mar 04 '24 Sale 332.62 4,436 1,475,502 31,587 Mar 05 05:43 PM Triplett Michael W Special Advisor Mar 04 '24 Sale 332.62 1,953 649,607 32,452 Mar 05 05:43 PM Cordani David Chairman & CEO Feb 27 '24 Option Exercise 139.22 2,000 278,440 338,783 Feb 27 05:48 PM Cordani David Chairman & CEO Feb 27 '24 Sale 345.04 2,000 690,075 336,783 Feb 27 05:48 PM Cordani David Chairman & CEO Feb 26 '24 Option Exercise 139.22 10,453 1,455,267 347,236 Feb 27 05:48 PM Cordani David Chairman & CEO Feb 26 '24 Sale 345.70 10,453 3,613,652 336,783 Feb 27 05:48 PM Cordani David Chairman & CEO Feb 23 '24 Option Exercise 139.22 6,319 879,731 343,102 Feb 27 05:48 PM Cordani David Chairman & CEO Feb 23 '24 Sale 345.24 6,319 2,181,592 336,783 Feb 27 05:48 PM Palmer Eric P See Remarks Feb 14 '24 Option Exercise 149.13 905 134,967 45,554 Feb 15 05:30 PM Cordani David Chairman & CEO Feb 13 '24 Option Exercise 139.22 7,462 1,038,860 336,783 Feb 13 05:27 PM Palmer Eric P See Remarks Feb 13 '24 Option Exercise 149.13 5,168 770,730 50,732 Feb 15 05:30 PM Palmer Eric P See Remarks Feb 13 '24 Sale 340.00 6,083 2,068,220 44,649 Feb 15 05:30 PM Cordani David Chairman & CEO Feb 12 '24 Option Exercise 139.22 2,073 288,603 331,394 Feb 13 05:27 PM Cordani David Chairman & CEO Feb 12 '24 Sale 336.81 2,073 698,198 329,321 Feb 13 05:27 PM Cordani David Chairman & CEO Feb 09 '24 Option Exercise 139.22 38,065 5,299,409 367,386 Feb 13 05:27 PM Cordani David Chairman & CEO Feb 09 '24 Sale 335.22 38,065 12,760,123 329,321 Feb 13 05:27 PM Palmer Eric P See Remarks Feb 09 '24 Sale 335.26 1,017 340,956 45,564 Feb 13 05:28 PM Agoglia Hoeltzel Mary T SVP Tax & Chief Acct. Officer Feb 07 '24 Option Exercise 78.03 4,867 379,796 6,969 Feb 09 05:04 PM Agoglia Hoeltzel Mary T SVP Tax & Chief Acct. Officer Feb 07 '24 Sale 330.48 4,867 1,608,446 2,102 Feb 09 05:04 PM Palmer Eric P See Remarks Feb 05 '24 Option Exercise 139.22 1,017 141,587 46,581 Feb 06 09:02 PM Palmer Eric P See Remarks Feb 02 '24 Option Exercise 139.22 5,684 791,326 51,248 Feb 06 09:02 PM Palmer Eric P See Remarks Feb 02 '24 Sale 325.00 5,684 1,847,300 45,564 Feb 06 09:02 PM Ryan Cynthia EVP, CHRO Aug 30 '23 Option Exercise 149.13 434 64,725 5,937 Aug 31 05:33 PM Ryan Cynthia EVP, CHRO Aug 29 '23 Option Exercise 149.13 3,012 449,195 9,271 Aug 31 05:33 PM Ryan Cynthia EVP, CHRO Aug 29 '23 Sale 282.22 3,768 1,063,405 5,503 Aug 31 05:33 PM Jones Nicole S EVP, General Counsel Aug 21 '23 Sale 276.86 7,819 2,164,768 30,069 Aug 23 05:19 PM Agoglia Hoeltzel Mary T SVP Tax & Chief Acct. Officer Aug 08 '23 Option Exercise 78.03 4,500 351,158 14,343 Aug 10 05:07 PM Agoglia Hoeltzel Mary T SVP Tax & Chief Acct. Officer Aug 08 '23 Sale 291.00 12,250 3,564,750 2,093 Aug 10 05:07 PM Evanko Brian C EVP, Chief Financial Officer Aug 03 '23 Option Exercise 78.03 570 44,480 31,902 Aug 04 05:21 PM Evanko Brian C EVP, Chief Financial Officer Aug 02 '23 Option Exercise 78.03 2,307 180,027 33,639 Aug 04 05:21 PM Evanko Brian C EVP, Chief Financial Officer Aug 02 '23 Sale 300.00 2,307 692,100 31,332 Aug 04 05:21 PM Neville Everett EVP, Solutions & Corp Devt. Jul 20 '23 Option Exercise 211.14 1,050 221,701 5,987 Jul 21 05:03 PM Neville Everett EVP, Solutions & Corp Devt. Jul 19 '23 Option Exercise 213.05 13,157 2,803,077 18,094 Jul 21 05:03 PM Neville Everett EVP, Solutions & Corp Devt. Jul 19 '23 Sale 295.21 13,157 3,884,078 4,937 Jul 21 05:03 PM Sanford Paul A EVP Operations Jul 19 '23 Sale 295.21 1,507 444,881 8,679 Jul 21 05:03 PM Neville Everett EVP, Solutions & Corp Devt. Jul 10 '23 Sale 277.61 466 129,366 4,937 Jul 12 06:43 PM
Index NDX, S&P 500
P/E 27.38
EPS (ttm) 8.02
Insider Own 0.31%
Shs Outstand 134.10M
Perf Week -9.37%
Market Cap 29.51B
Forward P/E 19.70
EPS next Y 11.15
Insider Trans -23.43%
Shs Float 133.98M
Perf Month -13.06%
Income 1.09B
PEG 3.47
EPS next Q 2.53
Inst Own 94.20%
Short Float 2.30%
Perf Quarter -5.63%
Sales 21.15B
P/S 1.40
EPS this Y 2.43%
Inst Trans 1.37%
Short Ratio 4.31
Perf Half Y 10.24%
Book/sh 15.91
P/B 13.80
EPS next Y 10.15%
ROA 8.40%
Short Interest 3.08M
Perf Year 33.09%
Cash/sh 5.98
P/C 36.71
EPS next 5Y 7.90%
ROE 58.81%
52W Range 162.59 - 263.37
Perf YTD -3.41%
Dividend Est. 2.44 (1.11%)
P/FCF 19.32
EPS past 5Y 14.12%
ROI 14.87%
52W High -16.63%
Beta 1.09
Dividend TTM 2.42 (1.10%)
Quick Ratio 1.13
Sales past 5Y 6.05%
Gross Margin 21.88%
52W Low 35.04%
ATR (14) 6.10
Dividend Ex-Date May 23, 2024
Current Ratio 1.26
EPS Y/Y TTM 0.45%
Oper. Margin 7.92%
RSI (14) 30.34
Volatility 3.26% 2.06%
Employees 15100
Debt/Eq 2.89
Sales Y/Y TTM -7.67%
Profit Margin 5.16%
Recom 1.92
Target Price 251.34
Option/Short Yes / Yes
LT Debt/Eq 2.43
EPS Q/Q -5.19%
Payout 29.50%
Rel Volume 1.13
Prev Close 218.41
Sales Surprise -2.57%
EPS Surprise -10.66%
Sales Q/Q -4.51%
Earnings May 01 BMO
Avg Volume 714.50K
Price 219.56
SMA20 -8.84%
SMA50 -10.77%
SMA200 -0.61%
Trades
Volume 805,659
Change 0.53%
Date
Action
Analyst
Rating Change
Price Target Change
Dec-12-23 Downgrade
Morgan Stanley
Overweight → Equal-Weight
$216
Oct-03-23 Initiated
UBS
Buy
$237
Jul-18-23 Initiated
Barclays
Equal Weight
$198
Jun-30-23 Initiated
Citigroup
Buy
$205
Apr-19-23 Downgrade
BofA Securities
Buy → Neutral
$240 → $200
Aug-17-22 Initiated
Credit Suisse
Outperform
$202
Jul-14-22 Upgrade
JP Morgan
Neutral → Overweight
$200
Apr-14-22 Upgrade
Stifel
Hold → Buy
$200 → $210
Mar-31-22 Upgrade
Morgan Stanley
Equal-Weight → Overweight
$201 → $214
Dec-14-21 Resumed
Evercore ISI
Outperform
$225
Oct-06-21 Downgrade
Morgan Stanley
Overweight → Equal-Weight
$208 → $196
Sep-29-21 Upgrade
JP Morgan
Underweight → Neutral
$200
Feb-04-21 Upgrade
Morgan Stanley
Equal-Weight → Overweight
$164
Aug-12-20 Initiated
Citigroup
Buy
$140
Jun-29-20 Upgrade
Raymond James
Mkt Perform → Outperform
$140
Jun-09-20 Upgrade
Morgan Stanley
Underweight → Equal-Weight
$120
Jun-09-20 Downgrade
JP Morgan
Neutral → Underweight
$115
Feb-28-20 Upgrade
JP Morgan
Underweight → Neutral
$120
Jan-17-20 Downgrade
Morgan Stanley
Equal-Weight → Underweight
$126 → $124
Aug-05-19 Downgrade
JP Morgan
Neutral → Underweight
$116
Show Previous Ratings
May-04-24 08:20AM
May-03-24 09:35AM
May-02-24 09:40AM
03:08AM
May-01-24 11:09PM
(Thomson Reuters StreetEvents) -11.27%
10:00PM
Loading…
10:00PM
11:54AM
08:31AM
08:15AM
07:53AM
07:19AM
(Associated Press Finance)
07:05AM
07:00AM
Apr-30-24 10:18AM
Apr-29-24 09:16AM
10:01AM
Loading…
Apr-24-24 10:01AM
Apr-17-24 07:00AM
01:09AM
Mar-22-24 09:40AM
Mar-19-24 09:50AM
Mar-08-24 11:30AM
Mar-01-24 08:56AM
Feb-27-24 12:01AM
Feb-19-24 08:00AM
Feb-15-24 09:50AM
Feb-14-24 09:45AM
Feb-08-24 09:37AM
Feb-07-24 11:10PM
(Thomson Reuters StreetEvents)
10:00AM
08:10AM
07:33AM
Loading…
07:33AM
07:18AM
(Associated Press Finance)
07:05AM
07:00AM
Feb-02-24 09:15AM
Jan-24-24 07:00AM
06:37AM
Dec-11-23 04:26PM
Dec-08-23 08:00PM
Dec-01-23 11:31AM
Nov-21-23 05:08AM
Nov-14-23 08:00AM
Nov-13-23 02:41PM
Nov-02-23 04:10PM
01:09AM
Nov-01-23 11:37PM
(Thomson Reuters StreetEvents)
11:41AM
09:16AM
07:25AM
(Associated Press Finance)
07:05AM
07:00AM
Oct-31-23 08:38AM
Oct-30-23 12:12PM
Oct-23-23 01:52AM
Oct-18-23 07:00AM
Oct-17-23 10:25AM
Oct-10-23 07:44AM
Oct-04-23 12:24AM
Oct-03-23 11:32AM
Sep-26-23 11:43AM
Sep-14-23 05:49AM
Aug-11-23 11:06AM
Aug-02-23 01:41PM
12:33PM
11:35AM
07:57AM
07:11AM
07:05AM
07:00AM
Aug-01-23 08:00AM
Jul-31-23 09:45AM
Jul-25-23 11:52PM
11:49PM
Jul-20-23 05:37AM
Jul-19-23 07:00AM
Jul-14-23 03:42AM
Jun-21-23 08:00PM
Jun-09-23 08:11AM
May-25-23 11:46AM
May-18-23 04:16PM
08:15AM
May-11-23 09:30AM
May-08-23 08:00AM
May-04-23 12:17AM
(Thomson Reuters StreetEvents)
May-03-23 11:50AM
07:21AM
07:05AM
07:00AM
May-01-23 07:42AM
Apr-26-23 08:00PM
Apr-24-23 07:09AM
Apr-21-23 08:22AM
Apr-19-23 12:28PM
09:31AM
08:39AM
Apr-18-23 04:05PM
Apr-13-23 08:49AM
Mar-28-23 04:01PM
Mar-04-23 08:16AM
Feb-26-23 08:25AM
CDW Corp. engages in the provision of information technology solutions to small, medium, and large business, government, education, and healthcare customers. It operates through the following segments: Corporate, Small Business, Public, and Other. The Public segment includes government agencies and education and healthcare institutions. The Other segment focuses on CDW UK and Canada. The company was founded in 1984 by Michael P. Krasny and is headquartered in Vernon Hills, IL.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
CORLEY CHRISTINA M See Remarks Dec 14 '23 Option Exercise 58.90 34,079 2,007,253 96,615 Dec 15 05:09 PM CORLEY CHRISTINA M See Remarks Dec 14 '23 Sale 220.94 34,079 7,529,302 62,536 Dec 15 05:09 PM CORLEY CHRISTINA M See Remarks Dec 13 '23 Option Exercise 58.90 700 41,230 63,236 Dec 15 05:09 PM CORLEY CHRISTINA M See Remarks Dec 13 '23 Sale 220.01 700 154,007 62,536 Dec 15 05:09 PM CORLEY CHRISTINA M See Remarks Nov 22 '23 Option Exercise 38.80 48,320 1,875,021 110,856 Nov 27 05:34 PM CORLEY CHRISTINA M See Remarks Nov 22 '23 Sale 217.23 48,320 10,496,614 62,536 Nov 27 05:34 PM LEAHY CHRISTINE A See Remarks Nov 16 '23 Option Exercise 39.10 7,054 275,841 75,676 Nov 17 04:52 PM LEAHY CHRISTINE A See Remarks Nov 15 '23 Option Exercise 39.11 44,383 1,735,820 113,005 Nov 17 04:52 PM LEAHY CHRISTINE A See Remarks Nov 15 '23 Sale 218.81 44,383 9,711,660 68,622 Nov 17 04:52 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite